Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucantime With and Without Fractional CO₂ Laser in Cutaneous Leishmaniasis
NCT07652021Phase 2Not yet recruiting
- Sponsor
- Combined Military Hospital Peshawar
- Start
- Aug 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by Combined Military Hospital Peshawar. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT07652021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07652021.